APA (7th ed.) Citation

Farid, K. M. N., Sauer, T., Schmitt, M., Müller-Tidow, C., & Schmitt, A. (2024). Symptomatic Patients with Hyperleukocytic FLT3-ITD Mutated Acute Myeloid Leukemia Might Benefit from Leukapheresis. Cancers, 16(1), 58. https://doi.org/10.3390/cancers16010058

Chicago Style (17th ed.) Citation

Farid, Kiavasch Mohammad Nejad, Tim Sauer, Michael Schmitt, Carsten Müller-Tidow, and Anita Schmitt. "Symptomatic Patients with Hyperleukocytic FLT3-ITD Mutated Acute Myeloid Leukemia Might Benefit from Leukapheresis." Cancers 16, no. 1 (2024): 58. https://doi.org/10.3390/cancers16010058.

MLA (9th ed.) Citation

Farid, Kiavasch Mohammad Nejad, et al. "Symptomatic Patients with Hyperleukocytic FLT3-ITD Mutated Acute Myeloid Leukemia Might Benefit from Leukapheresis." Cancers, vol. 16, no. 1, 2024, p. 58, https://doi.org/10.3390/cancers16010058.